Cual es la diferencia entre NOAEL y NOEL?

NOAEL (No Observed Adverse Effect Level): dosis mas alta sin efectos adversos. NOEL (No Observed Effect Level): dosis mas alta sin ningun efecto, incluyendo cambios no-adversos. NOAEL es el standard regulatorio porque enfoca en cambios con significado clinico.

Como se calcula el HED desde el NOAEL?

Human Equivalent Dose = NOAEL (mg/kg) x (Km animal / Km human). Km factors: human 37, dog 20, monkey 12, rat 6, mouse 3. Ejemplo: NOAEL rat 10 mg/kg -> HED = 10 x (6/37) = 1.6 mg/kg human. Luego aplicar safety factors.

Que safety factors se aplican al HED?

Minimo 10x para interspecies variability (diferencias farmacologicas/metabolicas) + 10x para human variability (diferencias individuales). Total 100x. Factores adicionales para: target nuevo, toxicidad severa, dose-response empinado, incertidumbre.

Como se distingue efecto adverso de adaptativo?

Adaptativo: respuesta fisiologica compensatoria, sin dano funcional, dentro de rango normal (ej. hipertrofia hepatica sin necrosis, induccion enzimatica). Adverso: impairment funcional, dano patologico, signs clinicos, severidad moderada-severa. Expert judgment documentado.

Determinacion de NOAEL en Estudios de Peptidos

Categorías: Metodología de Investigación, Protocolos de Seguridad, Información General

El NOAEL es el parametro critico de estudios toxicologicos. Su determinacion correcta es esencial para establecer dosis seguras en humanos.

Resumen Simplificado

NOAEL es la dosis sin efectos adversos; se determina en repeat-dose studies y se usa para calcular human starting dose.

Concepto de NOAEL

NOAEL definition. No Observed Adverse Effect Level. Highest dose. No adverse effects observed. In toxicology study. Not just no effects. NOEL. No Observed Effect Level. Any effect. Not just adverse. NOAEL vs NOEL. NOAEL is regulatory standard. Focus on adverse. Not all changes are adverse. Adverse effect definition. Change with functional impact. Or pathological significance. Not just adaptive response. Examples. Body weight change. Greater than 10% reduction. Clinical pathology. Outside normal range. Organ toxicity. Microscopic findings. Clinical signs. Neurological. Behavioral. Determination. Based on all findings. Integrated assessment. Weight of evidence. NOAEL is key. For starting dose. For safety margin. For clinical monitoring. Without valid NOAEL. Cannot proceed to clinical.

Diseño de estudios para NOAEL

Study design for NOAEL. Dose groups. Minimum three. Control. Vehicle only. Low dose. Expected clinical exposure. Or multiple. Mid dose. Intermediate. High dose. Maximum tolerated. Or limit dose. Sufficient separation. Between doses. To identify dose-response. Group size. Adequate for detection. Rodents. 10 per sex per group. Non-rodents. 3-4 per sex per group. Recovery groups. Assess reversibility. Duration. Repeat dose studies. As per clinical duration. Parameters measured. Clinical observations. Body weight. Food consumption. Ophthalmology. Clinical pathology. Hematology. Clinical chemistry. Urinalysis. Organ weights. Gross pathology. Histopathology. All tissues examined. Peer review. For quality. Design ensures. Findings detectable. Dose-response characterizable. NOAEL determinable. Poor design. Ambiguous NOAEL. Regulatory questions.

Evaluacion de findings toxicologicos

Finding evaluation process. Identify all changes. From control. Statistical analysis. Appropriate tests. Biological significance. Is change adverse? Severity. Mild. Moderate. Severe. Dose relationship. Present at lower doses? Increasing with dose? Reversibility. Recovery groups. Returns to normal? Adaptive vs adverse. Liver enlargement. Adaptive hypertrophy? Or toxic? Clinical pathology. Enzymes elevated. Evidence of injury. Histopathology correlation. Species-specific findings. Rat-specific. Not relevant to human. Historical control data. Is finding within range? Single animal finding. Outlier? Or treatment-related? Weight of evidence. Multiple parameters affected. Same organ. Same system. Strengthens case for adverse. Isolated finding. Minimal severity. May not be adverse. Integrated assessment. All findings considered. Together. Not in isolation. Determines NOAEL.

Diferenciacion de efectos adversos

Adverse vs non-adverse. Critical distinction. Non-adverse effects. Adaptive responses. Physiological compensation. Within normal range. No functional impairment. Examples. Enzyme induction. Liver hypertrophy. Without necrosis. Hormonal changes. Within compensatory range. Minimal histological changes. Without clinical correlate. Adverse effects. Functional impairment. Pathological changes. Clinical signs. Reduced survival. Reduced body weight. Greater than 10%. Organ damage. Necrosis. Inflammation. Fibrosis. Neoplasia. Clinical pathology changes. Outside normal range. Correlating with pathology. Severity considerations. Minimal. Not adverse usually. Mild. May be adverse. Moderate. Usually adverse. Severe. Definitely adverse. Expert judgment. Required for classification. Document rationale. For regulatory review. Proper classification. Determines NOAEL accuracy. Under-calling adverse. Underestimates risk. Over-calling. Wastes safety margin. Balance needed.

Calculo de dosis inicial humana

Starting dose calculation. From NOAEL. Human Equivalent Dose. HED. Interspecies scaling. Body surface area. Km factor. Human. 37 kg/m2. 60 kg adult. Dog. 20 kg/m2. Monkey. 12 kg/m2. Rat. 6 kg/m2. Mouse. 3 kg/m2. Calculation. HED = NOAEL x (Km animal / Km human). Example. NOAEL rat 10 mg/kg. HED = 10 x (6/37) = 1.6 mg/kg. Safety factors. Default 10x. Interspecies variability. Default 10x. Human variability. Combined 100x. Minimum. Additional factors. Novel target. Add factor. Severe toxicity. Add factor. Steep dose-response. Add factor. Uncertainty. Add factor. Maximum safe starting dose. HED / safety factors. Or lower. Clinical judgment. Pharmacologically active dose. May be lower. In vitro potency. Estimate active concentration. Clinical PK prediction. Estimate efficacious dose. Starting dose is. Lower of. Maximum safe dose. Or pharmacologically active estimate. Conservative approach. Protect first-in-human subjects. Start low. Go slow.

Documentacion regulatoria

Regulatory documentation. Nonclinical section. Integrated summary. Study reports. Full reports. All studies. Individual animal data. Available if requested. NOAEL determination. Clear statement. Dose level. mg/kg/day. Study reference. Justification. Why this dose. Findings at higher doses. Adverse nature explained. No adverse at this dose. Evidence presented. Safety margins. Comparison to clinical. Exposure margins. AUC ratio. Cmax ratio. Dose ratio. Starting dose justification. Calculation shown. Safety factors explained. Additional considerations. Vulnerable populations. Reproductive toxicity. Carcinogenicity potential. Pharmacological class. Related compounds. Known risks. Regulatory interaction. Pre-IND meeting. Discuss NOAEL. Agree on starting dose. Avoid surprises. Documentation quality. Determines review smoothness. Clear. Complete. Justified. Enables clinical trial initiation.

Hallazgos Clave

NOAEL es la dosis mas alta sin efectos adversos; NOEL considera cualquier efecto
Estudios requieren minimo 3 dose groups con recovery para reversibilidad assessment
Efectos adversos: functional impairment, pathological changes, clinical signs, severidad moderada-severa
HED = NOAEL x (Km animal/Km human); safety factors 10x interspecies + 10x human variability
Starting dose = min(HED/100, pharmacologically active estimate)
Documentacion incluye NOAEL justification, safety margins, calculation, regulatory discussion

Más artículos en Metodología de Investigación

Más artículos en Protocolos de Seguridad

Preguntas frecuentes

Cual es la diferencia entre NOAEL y NOEL?: NOAEL (No Observed Adverse Effect Level): dosis mas alta sin efectos adversos. NOEL (No Observed Effect Level): dosis mas alta sin ningun efecto, incluyendo cambios no-adversos. NOAEL es el standard regulatorio porque enfoca en cambios con significado clinico.
Como se calcula el HED desde el NOAEL?: Human Equivalent Dose = NOAEL (mg/kg) x (Km animal / Km human). Km factors: human 37, dog 20, monkey 12, rat 6, mouse 3. Ejemplo: NOAEL rat 10 mg/kg -> HED = 10 x (6/37) = 1.6 mg/kg human. Luego aplicar safety factors.
Que safety factors se aplican al HED?: Minimo 10x para interspecies variability (diferencias farmacologicas/metabolicas) + 10x para human variability (diferencias individuales). Total 100x. Factores adicionales para: target nuevo, toxicidad severa, dose-response empinado, incertidumbre.
Como se distingue efecto adverso de adaptativo?: Adaptativo: respuesta fisiologica compensatoria, sin dano funcional, dentro de rango normal (ej. hipertrofia hepatica sin necrosis, induccion enzimatica). Adverso: impairment funcional, dano patologico, signs clinicos, severidad moderada-severa. Expert judgment documentado.

Volver a la biblioteca de investigación